Striatal dopamine transporter function in dementia with Lewy bodies and Parkinson's disease

European Journal of Nuclear Medicine

Volumn 28, Issue 10, 2001, Pages 1523-1528

  Shah, Nirav R ^a   Bracken, Michael B ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Dementia with Lewy bodies; Dopamine transporter; Motor symptoms; Parkinson's disease; Single photon emission tomography

Indexed keywords

ANTIPARKINSON AGENT; BETA CIT I 123; DOPAMINE TRANSPORTER; RADIOLIGAND; UNCLASSIFIED DRUG;

ADULT; AGE; AGED; ARTICLE; CAMERA; CLINICAL ARTICLE; CONTROLLED STUDY; DEMENTIA; DIFFERENTIAL DIAGNOSIS; DISEASE DURATION; DRUG WITHDRAWAL; FEMALE; HUMAN; LEWY BODY; MALE; MOTOR ACTIVITY; PARKINSON DISEASE; RATING SCALE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

AGED; AGED, 80 AND OVER; CORPUS STRIATUM; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; HUMANS; LEWY BODY DISEASE; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MIDDLE AGED; NERVE TISSUE PROTEINS; PARKINSON DISEASE; STRIATONIGRAL DEGENERATION; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0034789751     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002590100571     Document Type: Article

References (35)

1. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: A clinico pathological study of 100 cases
2. An estimate of the incidence of dementia in idiopathic Parkinson's disease
3. Temporal pattern of cognitive decline and incontinence is different in Alzheimer's disease and diffuse Lewy body disease
4. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop
5. Report of the second dementia with Lewy body international workshop: Diagnosis and treatment. Consortium on Dementia with Lewy Bodies
6. 123I-beta-CIT single-photon emission tomography in dementia of the Alzheimer- type and diffuse Lewy body disease
7. Nigrostriatal dopaminergic activities in dementia with Lewy bodies in relation to neuroleptic sensitivity: Comparisons with Parkinson's disease
8. Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: Rostrocaudal distribution
9. In-vivo demonstration of dopaminergic degeneration in dementia with Lewy bodies
10. Neurotransmitters in basal ganglia and cortex of Alzheimer's disease with and without Lewy bodies
11. Comparison of extrapyramidal features in 31 pathologically confirmed cases of diffuse Lewy body disease and 34 pathologically confirmed cases of Parkinson's disease
12. Motor and cognitive function in Lewy body dementia: Comparison with Alzheimer's and Parkinson's diseases
13. Disability and progression in Parkinson's disease
14. Relationship of motor symptoms to intellectual deficits in Parkinson disease
15. One year follow-up of parkinsonism in dementia with Lewy bodies
16. What features improve the accuracy of clinical diagnosis in Parkinson's disease: A clinicopathologic study
17. Unified Parkinson's disease rating scale
18. The dosimetry of iodine-123 labelled 2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane
19. 123I] beta-CIT binding to dopamine transporters in healthy human subjects
20. 123I] beta-CIT and SPECT. Correlation with clinical findings and comparison with multiple system atrophy and progressive supranuclear palsy
21. The UPDRS scale as a means of identifying extrapyramidal signs in patients suffering from dementia with Lewy bodies
22. A 3-year randomized trial of ropinirole and bromocriptine in early Parkinson's disease
23. Double-blind comparison of pramipexole and bromocriptine treatment with placebo in advanced Parkinson's disease
24. Validity of current clinical criteria for Alzheimer's disease, vascular dementia and dementia with Lewy bodies
25. Accuracy of the clinical diagnoses of Lewy body disease, Parkinson disease, and dementia with Lewy bodies: A clinicopathologic study
26. Sensitivity and specificity of three clinical criteria for dementia with Lewy bodies in an autopsy-verified sample
27. Diagnosing dementia with Lewy bodies
28. Prospective validation of consensus criteria for the diagnosis of dementia with Lewy bodies
29. Imaging of dopamine transporters with iodine-123-beta-CIT and SPECT in Parkinson's disease
30. 123I]beta-CIT striatal uptake correlates with symptom severity in Parkinson's disease
31. Olanzapine and clozapine: Comparative effects on motor function in hallucinating PD patients
32. The neuropathologic basis of different clinical subgroups of Parkinson's disease
33. Comparison between the decrease of dopamine transporter and that of L-dopa uptake for detection of early to advanced stage of Parkinson's disease in animal models
34. Demenz mit lewy-körperchen